51. Impact of Glucosamine Supplementation on Gut Health
- Author
-
Richard A. Stecker, Martin Purpura, Jason Theodosakis, Jessica M. Moon, Craig J. Wissent, Peter Finnegan, Carolyn M. Slupsky, Maria L. Marco, Kayla M. Ratliff, Chad M. Kerksick, Hanna Lee, and Ralf Jäger
- Subjects
0301 basic medicine ,Male ,Constipation ,Pilot Projects ,Oral and gastrointestinal ,chemistry.chemical_compound ,Feces ,0302 clinical medicine ,Glucosamine ,TX341-641 ,stool ,Defecation ,Phylogeny ,Cross-Over Studies ,Nutrition and Dietetics ,Stomach ,metabolomics ,Healthy Volunteers ,medicine.anatomical_structure ,030220 oncology & carcinogenesis ,6.1 Pharmaceuticals ,Female ,medicine.symptom ,Adult ,medicine.medical_specialty ,Clinical Trials and Supportive Activities ,Placebo ,Article ,diversity ,03 medical and health sciences ,Bloating ,Food Sciences ,Double-Blind Method ,Polysaccharides ,Clinical Research ,Internal medicine ,Complementary and Integrative Health ,medicine ,Metabolome ,microbiota ,Humans ,Nutrition ,business.industry ,Nutrition. Foods and food supply ,Prevention ,Evaluation of treatments and therapeutic interventions ,gut health ,gastrointestinal ,Gastrointestinal Microbiome ,Gastrointestinal Tract ,030104 developmental biology ,Endocrinology ,chemistry ,Dietary Supplements ,Gastrointestinal function ,business ,Digestive Diseases ,Food Science - Abstract
Glucosamine (GLU) is a natural compound found in cartilage, and supplementation with glucosamine has been shown to improve joint heath and has been linked to reduced mortality rates. GLU is poorly absorbed and may exhibit functional properties in the gut. The purpose of this study was to examine the impact of glucosamine on gastrointestinal function as well as changes in fecal microbiota and metabolome. Healthy males (n = 6) and females (n = 5) (33.4 ± 7.7 years, 174.1 ± 12.0 cm, 76.5 ± 12.9 kg, 25.2 ± 3.1 kg/m2, n = 11) completed two supplementation protocols that each spanned three weeks separated by a washout period that lasted two weeks. In a randomized, double-blind, placebo-controlled, crossover fashion, participants ingested a daily dose of GLU hydrochloride (3000 mg GlucosaGreen®, TSI Group Ltd., Missoula, MT, USA) or maltodextrin placebo. Study participants completed bowel habit and gastrointestinal symptoms questionnaires in addition to providing a stool sample that was analyzed for fecal microbiota and metabolome at baseline and after the completion of each supplementation period. GLU significantly reduced stomach bloating and showed a trend towards reducing constipation and hard stools. Phylogenetic diversity (Faith’s PD) and proportions of Pseudomonadaceae, Peptococcaceae, and Bacillaceae were significantly reduced following GLU consumption. GLU supplementation significantly reduced individual, total branched-chain, and total amino acid excretion, with no glucosamine being detected in any of the fecal samples. GLU had no effect on fecal short-chain fatty acids levels. GLU supplementation provided functional gut health benefits and induced fecal microbiota and metabolome changes.
- Published
- 2021